On the evening of December 12, Tengsheng Bo Pharmaceutical announced that new in vitro chimeric virus experiments neutralized data indicate that its combination therapy of ampavirus monoclonal antibody/romizumab (previously known as BRII-19...
Tengsheng Bo medicine omicron brii Tengsheng Huachuang Novel coronavirus
12-12
![Domestic new crown special drug is effective for Omicron! Zhong Nanshan: It is very valuable to promote in the world[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
